Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.

Daneshpazhooh M, Kamyab K, Kalantari MS, Balighi K, Naraghi ZS, Shamohammadi S, Mortazavizadeh SM, Ramezani A, Chams-Davatchi C.

Clin Exp Dermatol. 2014 Jan;39(1):41-7. doi: 10.1111/ced.12187. Epub 2013 Jun 19.

PMID:
23782219
2.

Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.

Daneshpazhooh M, Zafarmand Sedigh V, Balighi K, Hosseini SH, Ramezani A, Kalantari MS, Ghandi N, Ghiasi M, Nikoo A, Chams-Davatchi C.

J Am Acad Dermatol. 2016 Jun;74(6):1160-5. doi: 10.1016/j.jaad.2015.10.051. Epub 2016 Feb 17.

PMID:
26896293
3.

Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.

Kwon EJ, Yamagami J, Nishikawa T, Amagai M.

J Eur Acad Dermatol Venereol. 2008 Sep;22(9):1070-5. doi: 10.1111/j.1468-3083.2008.02715.x. Epub 2008 Apr 10.

PMID:
18410336
4.
5.

Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.

Daneshpazhooh M, Chams-Davatchi C, Khamesipour A, Mansoori P, Taheri A, Firooz A, Mortazavi H, Esmaili N, Dowlati Y.

J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1319-24.

PMID:
17958835
6.

Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.

Cheng SW, Kobayashi M, Kinoshita-Kuroda K, Tanikawa A, Amagai M, Nishikawa T.

Br J Dermatol. 2002 Aug;147(2):261-5.

PMID:
12174096
7.

Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.

Nagasaka T, Fujii Y, Ishida A, Handa M, Tanikawa A, Amagai M, Nishikawa T.

Br J Dermatol. 2008 Apr;158(4):685-90. doi: 10.1111/j.1365-2133.2007.08416.x. Epub 2008 Jan 30.

PMID:
18241273
8.

ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.

Abasq C, Mouquet H, Gilbert D, Tron F, Grassi V, Musette P, Joly P.

Arch Dermatol. 2009 May;145(5):529-35. doi: 10.1001/archdermatol.2009.9.

PMID:
19451496
9.

[Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].

Zhong S, Qiu YF, Han BB, Zhao JY, Zhu XJ, Chen XX.

Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Jun 18;43(3):414-5. Chinese.

10.
11.

Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.

Mentink LF, de Jong MC, Kloosterhuis GJ, Zuiderveen J, Jonkman MF, Pas HH.

Br J Dermatol. 2007 Apr;156(4):635-41. Epub 2007 Jan 30.

PMID:
17263817
12.

Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.

Schmidt E, Dähnrich C, Rosemann A, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Hashimoto T, Bröcker EB, Recke A, Rose C, Zillikens D.

Exp Dermatol. 2010 May;19(5):458-63. doi: 10.1111/j.1600-0625.2010.01069.x. Epub 2010 Feb 16.

PMID:
20163452
13.

Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.

Hallaji Z, Mortazavi H, Lajevardi V, Tamizifar B, AmirZargar A, Daneshpazhooh M, Chams-Davatchi C.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):275-80. doi: 10.1111/j.1468-3083.2009.03408.x. Epub 2009 Aug 26.

PMID:
19709345
14.

A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.

Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K, Iwatsuki K.

J Dermatol Sci. 2013 Jun;70(3):190-5. doi: 10.1016/j.jdermsci.2013.02.011. Epub 2013 Mar 15.

PMID:
23602628
15.

Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.

Barnadas MA, Rubiales MV, Gich I, Gelpí C.

Int J Dermatol. 2015 Nov;54(11):1261-8. doi: 10.1111/ijd.12768. Epub 2015 Mar 4.

PMID:
25754029
16.

The value of anti-desmoglein enzyme-linked immunosorbent assay in the immunological follow-up of pemphigus.

Bellon N, André C, Sbidian E, Ortonne N, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.

Dermatology. 2014;229(3):256-62. doi: 10.1159/000365079. Epub 2014 Sep 10.

PMID:
25227321
17.

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.

Eming R, Rech J, Barth S, Kalden JR, Schuler G, Harrer T, Hertl M.

Dermatology. 2006;212(2):177-87.

PMID:
16484825
18.

Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study.

Bracke S, Speeckaert R, Van Geel N, De Bacquer D, Lambert J.

Eur J Dermatol. 2013 Jan-Feb;23(1):33-9. doi: 10.1684/ejd.2012.1901.

PMID:
23302186
19.

Correlation of conventional and conformational anti-desmoglein antibodies with phenotypes and disease activities in patients with pemphigus vulgaris.

Li Z, Zhang J, Xu H, Jin P, Feng S, Wang B.

Acta Derm Venereol. 2015 Apr;95(4):462-5. doi: 10.2340/00015555-1961.

20.

Direct immunofluorescence of plucked hair for evaluation of immunologic remission in pemphigus vulgaris.

Daneshpazhooh M, Naraghi ZS, Ramezani A, Ghanadan A, Esmaili N, Chams-Davatchi C.

J Am Acad Dermatol. 2011 Dec;65(6):e173-7. doi: 10.1016/j.jaad.2010.09.721. Epub 2011 Jun 22.

PMID:
21696851

Supplemental Content

Support Center